Alejandro Fernandez Martell

Working in Cell and Bioprocess Engineering to develop better cell-based medicines. Research Associate at @sheffielduni. Co-founder of @SpringfBiotech.

[CRISPR Therapeutics @CRISPRTX]

CRISPR COO Dr. Lawrence Klein joins other panelists tomorrow to discuss gene editing with BioPharma Dive reporter @NedPagliarulo. Tune in: https://t.co/hE0xXccKds

[Manufacturing at Innovate UK Business Connect @IUK_Mfg]

Have you got your innovation and collaboration partners in place for the #ISCF Manufacturing Made Smarter supply chain competitions. Competition closes on 7th October.
Need help? Speak to the KTN.

[Broad Institute @broadinstitute]

A new class of base editor, developed in a collaboration between @davidrliu, Joseph Mougous @UW, @VamsiMootha, and colleagues, enables precision editing of mitochondrial DNA (mtDNA). Read more: https://t.co/6SYEPAzor0

[McKinsey Global Institute @McKinsey_MGI]

“The global bioeconomy is about to take off as manufacturers choose biology as the method of choice to efficiently produce high-performance, sustainable products.” @SynBioBeta CEO @johncumbers details our latest report. https://t.co/D9103Qvlng

[Eric Topol @EricTopol]

If these trends continue, Mexico and India will join Brazil in exceeding the US daily death rate in the next 10 days
BRIMUS, June 15
Latin America is now accounting for 50% of global deaths

[Alejandro Fernandez Martell @afdzmartell]

How #AI and #machinelearning are helping to fight #covid19 https://t.co/xc58wutV4x via @wef

[Daniel Burkhardt @DBBurkhardt]

Want to learn how to analyze single cell data with machine learning? Then join the @KrishnaswamyLab and @YaleGenetics online for our May 2020 Machine Learning for Single Cell Analysis Workshop! Registration is now open 🎉🥳📅

Learn more 👇
https://t.co/Bmq5L4OBsH

[Eric Topol @EricTopol]

The best diagram of the #SARSCoV2 virus sucker, with its protein components, that I've seen
Link to come later from accompanying @NEJM essay

[Alejandro Fernandez Martell @afdzmartell]

Good review of 15 drug repurposing studies currently being tested to treat #COVID19
https://t.co/qYcgBmlnV9

[Alejandro Fernandez Martell @afdzmartell]

What makes a drug discovery consortium successful? Medicines Discovery Catapult has put together the desirable factors that can underpin the success of a consortia focused on drug discovery.
https://t.co/pvQtKkAl52

[Alejandro Fernandez Martell @afdzmartell]

Excellent article dissecting the key molecular structures of COVID-19 genome. Bad News Wrapped in Protein: Inside the Coronavirus Genome. https://t.co/zXWWx3LSDV

[Lynn Fang @linjing_fang]

(1/2) Please RT this invaluable "Handbook of COVID-19 Prevention and Treatment" written by experts from The First Affiliated Hospital, Zhejiang University School of Medicine, China. Available in English and Chinese as of now. #FightCOVID19
https://t.co/OzuQC3oZri

[Ed Yong is not here @edyong209]

I wrote about the new coronavirus itself--where it came from, why it's behaving in the way it's behaving, how it infects and kills, and what the summer might bring. It's early days, of course, but this serves as a rough preliminary portrait of SARS-CoV-2. https://t.co/GL4wrlvN0r

[Alejandro Fernandez Martell @afdzmartell]

Collaboration is key to achieve innovation (in terms of automation, reproducibility and analytics) and change the way we manufacture cell and gene therapy products
https://t.co/XKhUlSPqsw via Labiotech_eu

[Alliance for Regenerative Medicine (ARM) @alliancerm]

Just released! #Genetherapy & #celltherapy have the potential to provide a significant benefit to rare disease patients. Check out ARM's newest report & see the state of the sector for #regenmed & #raredisease >> https://t.co/tJq8XVtW2e
#RareDiseaseDay #RareDiseaseWeek

[SynBioBeta @SynBioBeta]

#Artificialintelligence yields new antibiotic:
A #deeplearning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria. https://t.co/RxvdkBZjlb #AI #antibioticresistance #amr

[Alejandro Fernandez Martell @afdzmartell]

Cellular & Gene Therapy Guidances https://t.co/TKClcomPR7

[Alejandro Fernandez Martell @afdzmartell]

Manufacturing bottlenecks, paired with quality control and talent pool concerns, raise questions about the pace of progress in gene therapy #genetherapy
https://t.co/nwcSCi8YVM

[Alejandro Fernandez Martell @afdzmartell]

The demand for two technologies developed in the 70s, the viral vector and plasmids, remains a challenge in the gene and cell therapy landscape! https://t.co/fDUJKplZ69 via @GENbio

[Alejandro Fernandez Martell @afdzmartell]

The demand for two technologies developed in the 70s, the viral vector and plasmids, remains a challenge in the gene and cell therapy landscape https://t.co/fDUJKplZ69 via @GENbio